Anabio R&D
🇻🇳Vietnam
Clinical Trials
6
Active:0
Completed:6
Trial Phases
1 Phases
Not Applicable:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Not Applicable
6 (100.0%)Efficacy of LiveSpo COLON as a Supportive Treatment for Inflammatory Bowel Disease (IBD)
Not Applicable
Completed
- Conditions
- Inflammatory Bowel Diseases
- First Posted Date
- 2024-10-11
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- Anabio R&D
- Target Recruit Count
- 60
- Registration Number
- NCT06637683
- Locations
- 🇻🇳
Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam
Effects of LiveSpo X-SECRET in SupportiveTreatment of Vaginitis
Not Applicable
Completed
- Conditions
- Vaginitis
- Interventions
- Drug: 0.9% NaCl physiological salineCombination Product: LiveSpo X-secret
- First Posted Date
- 2023-12-11
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- Anabio R&D
- Target Recruit Count
- 120
- Registration Number
- NCT06165354
- Locations
- 🇻🇳
Hanoi Obstetrics and Gynecology Hospital, Ba Dinh, Hanoi, Vietnam
🇻🇳Centers for Disease Control and Prevention, Bac Ninh, Vietnam
Effectiveness of Bacillus Spore Probiotics in Reducing Constipation, Anorexia, and Slow Weight Gain in Children
Not Applicable
Completed
- Conditions
- Weight GainAnorexiaConstipation
- First Posted Date
- 2023-12-04
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Anabio R&D
- Target Recruit Count
- 201
- Registration Number
- NCT06154525
- Locations
- 🇻🇳
National Institute of Nutrition, Hanoi, Vietnam
Efficacy of Probiotics (LiveSpo Navax) in Preventing Respiratory Diseases in Children
Not Applicable
Completed
- Conditions
- Respiratory DiseaseRespiratory Infections in Children
- Interventions
- Combination Product: Probiotic 2Drug: 0.9% NaCl physiological salineCombination Product: Probiotic 1
- First Posted Date
- 2023-11-28
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Anabio R&D
- Target Recruit Count
- 600
- Registration Number
- NCT06148194
- Locations
- 🇻🇳
Son Tay Province, Hanoi, Hanoi, Vietnam
LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media
Not Applicable
Completed
- Conditions
- Upper Respiratory Tract Infections
- Interventions
- Drug: 0.9% NaCl physiological saline Nasal-sprayingCombination Product: LiveSpo Navax®
- First Posted Date
- 2023-04-07
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- Anabio R&D
- Target Recruit Count
- 175
- Registration Number
- NCT05804123
- Locations
- 🇻🇳
Thai Binh University of Medicine and Pharmacy, Thai Binh Medical University Hospital and Thai Binh Children's Hospital, Thai Binh, Vietnam
- Prev
- 1
- 2
- Next
News
No news found